Search results for: Institute for Clinical and Economic Review (ICER)
Filter search results
Federico Augustovski
8 June 2025
…Regional Issues. He leads the PAHO-affiliated PROVAC Center of Excellence and a team focused on clinical and economic evaluations of health technologies. He holds a Medical Degree from the University…
Measuring Health Output, Productivity and Equity
20 April 2010
…aspect of the 2004-5 Review he completed for the Office of National Statistics (ONS), intended to assess existing measures of government output and productivity, and recommend improvements. With respect to…
“You Don’t Always Get What You Want”: Output Distortion and NHS Waiting Time Targets
18 December 2018
…hospital level (the star-rating) and strong sanctions for poor performing hospital managers. This regime was dubbed ‘targets and terror’. The policy involved a ratcheting effect. The maximum waiting time for…
A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”
1 May 2018
This OHE Consulting Report reviews “Estimated costs of production and potential prices of medicines for the World Health Organization Essential Medicines List” (Hill et al., 2018) in which the authors…
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?
1 November 2020
…literature and conceptual explication of the problem: By convention, values for generic ‘preference-based’ measures, such as the EQ-5D, are anchored at 1 = full health and = dead. This paper…
Prescribing, Budgets and Fundholding in General Practice
10 January 1997
…practice was a particular focus of attention. The preparatory White Paper (CM 555, 1989) noted that prescription medicines formed the largest single expenditure item for the Family Practitioner Services and…
OHE is Leading Research to Develop EQ-5D ‘Bolt-ons’ for Cognition and Vision
24 May 2019
…and focus groups. By reviewing health status measures that are currently used in the context of cognitive impairment and visual impairment, we can understand how the impact of cognition and…
The Spanish Medicines Market Today
9 February 2011
…in the measures taken. For example, Andalusia, Catalonia and the Basque Country have taken the lead in pharmacoeconomic evaluations; Andalusia, the Canaries, Castilla-La Mancha, Castilla y Leon and Valencia have imposed…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
23 September 2019
…of the current state of HTA and contracting for antibiotics in France, Germany, Italy, Sweden, and the UK (England and Scotland), and of the recent proposals in the literature for…